Nimble Therapeutics Appoints Shelley Allen As Head of Drug Discovery and Munir Mosaheb As Head of Biology
Nimble Therapeutics Appoints Shelley Allen As Head of Drug Discovery and Munir Mosaheb As Head of Biology
04/03/24, 3:20 PM
Location
madisonIndustry
therapeutics
biotechnology
Position
head of biology
head of drug discovery
Nimble Therapeutics announced the opening of a second R&D site in Philadelphia, PA, focusing on progressing their pipeline of orally-delivered peptide therapeutics. In addition, the company appointed Shelley Allen as Head of Drug Discovery and Munir Mosaheb as Head of Biology to spearhead the drug discovery efforts and catalyze the build out of the Philadelphia site and team.
Company Info
Location
500 south rosa road
madison, wisconsin, united states
Additional Info
Nimble is a biotechnology company dedicated to delivering on the promise of peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine, Nimble is advancing its internal pipeline and continues to support several partnered programs.